# Sun Pharmaceutical Industries Ltd has declared its acquisition of US-based healthcare company Organon & Co in an all-cash deal worth USD 11.75 billion.

*biotech · news · 2026-04-27 · Devdiscourse*

## Key points

- Sun Pharma is acquiring US-based Organon & Co for USD 11.75 billion in cash.
- The acquisition is valued at USD 14 per Organon share.
- Sun Pharma's shares surged over 7 percent following the acquisition announcement.
- This deal strengthens Sun Pharma's presence in women's health and biosimilars.

**Companies:** Sun Pharmaceutical Industries Ltd, Organon & Co
**Countries:** India, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/business/3888029-sun-pharmas-billion-dollar-leap-acquisition-of-organon)

---

Canonical: https://newsio.io/n/01b49b24-2ad0-46f5-9468-c081d2a7cbd4/sun-pharmaceutical-industries-ltd-has-declared-its-acquisition-of-us-based-healt
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works